A Pilot Study of Aminolaevulinic Acid (ALA) Photodynamic Therapy (PDT) in Patients With Cervical Persistent High Risk HPV Infection or Cervical Intraepithelial Neoplasia

Trial Profile

A Pilot Study of Aminolaevulinic Acid (ALA) Photodynamic Therapy (PDT) in Patients With Cervical Persistent High Risk HPV Infection or Cervical Intraepithelial Neoplasia

Completed
Phase of Trial: Phase II

Latest Information Update: 04 May 2017

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
  • Most Recent Events

    • 14 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 09 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Nov 2016, as reported by ClinicalTrials.gov.
    • 09 Dec 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top